Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $160.28 million. The enterprise value is $74.20 million.
| Market Cap | 160.28M |
| Enterprise Value | 74.20M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 35.78 million shares outstanding. The number of shares has increased by 121.67% in one year.
| Shares Outstanding | 35.78M |
| Shares Change (YoY) | +121.67% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 32.17% |
| Owned by Institutions (%) | 41.93% |
| Float | 19.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.01 |
| Forward PS | 39.84 |
| PB Ratio | 2.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 26.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.95 |
| Quick Ratio | 7.82 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.30% and return on invested capital (ROIC) is -73.86%.
| Return on Equity (ROE) | -58.30% |
| Return on Assets (ROA) | -41.50% |
| Return on Capital (ROIC) | -73.86% |
| Revenue Per Employee | $49,286 |
| Profits Per Employee | -$877,143 |
| Employee Count | 56 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.95% in the last 52 weeks. The beta is 0.14, so OBIO's price volatility has been lower than the market average.
| Beta (1Y) | 0.14 |
| 52-Week Price Change | -69.95% |
| 50-Day Moving Average | 5.53 |
| 200-Day Moving Average | 6.60 |
| Relative Strength Index (RSI) | 31.60 |
| Average Volume (30 Days) | 48,143 |
Short Selling Information
The latest short interest is 858,022, so 2.40% of the outstanding shares have been sold short.
| Short Interest | 858,022 |
| Short Previous Month | 876,400 |
| Short % of Shares Out | 2.40% |
| Short % of Float | 4.41% |
| Short Ratio (days to cover) | 16.42 |
Income Statement
In the last 12 months, OBIO had revenue of $2.76 million and -$49.12 million in losses. Loss per share was -$1.48.
| Revenue | 2.76M |
| Gross Profit | 2.57M |
| Operating Income | -51.51M |
| Pretax Income | -49.12M |
| Net Income | -49.12M |
| EBITDA | -48.20M |
| EBIT | -49.12M |
| Loss Per Share | -$1.48 |
Balance Sheet
The company has $87.60 million in cash and $1.69 million in debt, giving a net cash position of $85.91 million or $2.40 per share.
| Cash & Cash Equivalents | 87.60M |
| Total Debt | 1.69M |
| Net Cash | 85.91M |
| Net Cash Per Share | $2.40 |
| Equity / Book Value | 68.04M |
| Book Value Per Share | 1.90 |
| Working Capital | 77.91M |
Cash Flow
In the last 12 months, operating cash flow was -$46.13 million and capital expenditures -$78,000, giving a free cash flow of -$46.21 million.
| Operating Cash Flow | -46.13M |
| Capital Expenditures | -78,000 |
| Free Cash Flow | -46.21M |
| FCF Per Share | -$1.39 |
Margins
Gross margin is 93.26%, with operating and profit margins of -1,866.16% and -1,779.71%.
| Gross Margin | 93.26% |
| Operating Margin | -1,866.16% |
| Pretax Margin | -1,779.71% |
| Profit Margin | -1,779.71% |
| EBITDA Margin | -1,746.41% |
| EBIT Margin | -1,779.71% |
| FCF Margin | -1,674.09% |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -121.67% |
| Shareholder Yield | -121.67% |
| Earnings Yield | -30.68% |
| FCF Yield | -28.86% |
Analyst Forecast
The average price target for OBIO is $17.00, which is 279.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 279.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -0.82 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.82 |
| Piotroski F-Score | 3 |